Tcr αβ-depleted progenitor cell graft with additional memory t-cell dli, plus selected use of blinatumomab, in naÏve t-cell depleted haploidentical donor hematopoieitc cell transplantation for hematologic malignancies

Conditions:   Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Myelodysplastic Syndromes (MDS);   NK-Cell Leukemia;   Hodgkin Lymphoma;   Non Hodgkin Lymphoma (NHL);   Juvenile Myelomonocytic Leukemia (JMML);   Chronic Myeloid Leukemia (CML) Interventions:   Drug: Cyclophosphamide;   Biological: Fludarabine;   Drug: Thiotepa;   Drug: Melphalan;   Biological: G-csf;   Drug: Mesna;   Device: CliniMACS;   Biological: ATG (rabbit);   Drug: Blinatumomab;   Biological: TCRα/β+;   Biological: CD19+;   Biological: CD45RA-depleted  DLI Sponsor:   St. Jude Children's Research Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials